Compound 1346
Identifiers
- Canonical SMILES:
C[C@H](N)C(=O)N[C@@H](Cc1cccc(c1)C(N)=O)C(=O)N1C[C@H]([C@@H]1c1ccccc1)C(=O)N[C@H]1CCc2ccccc12
- IUPAC name:
1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-(3-carbamoylphenyl)propanoyl]-N-[(1S)-2,3-dihydro-1H-inden-1-yl]-2-phenylazetidine-3-carboxamide
- InChi:
InChI=1S/C32H35N5O4/c1-19(33)30(39)36-27(17-20-8-7-12-23(16-20)29(34)38)32(41)37-18-25(28(37)22-10-3-2-4-11-22)31(40)35-26-15-14-21-9-5-6-13-24(21)26/h2-13,16,19,25-28H,14-15,17-18,33H2,1H3,(H2,34,38)(H,35,40)(H,36,39)/t19-,25+,26-,27-,28-/m0/s1
- InChiKey:
KIZPRSYGYKLCEQ-FZHCFFITSA-N
External links
![]() 168317990 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
XIAP / Smac | 8.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 553.27 g/mol | |||
HBA | 9 | |||
HBD | 6 | |||
HBA + HBD | 15 | |||
AlogP | 2.00 | |||
TPSA | 147.62 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152824 | 24 | XIAP P98170 |
|
Biochemical assay | alphascreen | pIC50 (half maximal inhibitory concentration, -log10) | 8.00 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6639 | D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide | DB07133 | |
0.6596 | RU82197 | DB03268 | |
0.6496 | Quinaprilat | DB14217 | |
0.6471 | (S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide | DB04578 | |
0.6446 | D-phenylalanyl-N-benzyl-L-prolinamide | DB07143 | |
0.6434 | (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide | DB04724 | |
0.6277 | Palonosetron | DB00377 | |
0.6212 | Semagacestat | DB12463 | |
0.6172 | D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide | DB07027 | |
0.6172 | 1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide | DB02628 | |
0.6144 | RU85053 | DB03712 | |
0.6124 | D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide | DB07005 | |
0.6124 | (R)-Praziquantel | DB11749 | |
0.6124 | Praziquantel | DB01058 | |
0.6103 | Tiropramide | DB13091 |